Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

A rapid and selective HPLC-UV method for the quantitation of efavirenz in plasma from patients on concurrent HIV/AIDS and tuberculosis treatments.

Bienvenu E, Hoffmann KJ, Ashton M, Kayumba PC.

Biomed Chromatogr. 2013 Nov;27(11):1554-9. doi: 10.1002/bmc.2959. Epub 2013 Jun 18.

PMID:
23780715
3.
5.
6.

Rapid method for the quantitative determination of efavirenz in human plasma.

Mogatle S, Kanfer I.

J Pharm Biomed Anal. 2009 Jul 12;49(5):1308-12. doi: 10.1016/j.jpba.2009.03.008. Epub 2009 Mar 20.

PMID:
19375262
7.

A sensitive and selective liquid chromatography/tandem mass spectrometry method for quantitative analysis of efavirenz in human plasma.

Srivastava P, Moorthy GS, Gross R, Barrett JS.

PLoS One. 2013 Jun 5;8(6):e63305. doi: 10.1371/journal.pone.0063305. Print 2013.

8.

Quantitative determination of efavirenz (DMP 266), a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection.

Veldkamp AI, van Heeswijk RP, Meenhorst PL, Mulder JW, Lange JM, Beijnen JH, Hoetelmans RM.

J Chromatogr B Biomed Sci Appl. 1999 Oct 29;734(1):55-61.

PMID:
10574190
9.

High-performance liquid chromatography method for analyzing the antiretroviral agent efavirenz in human plasma.

Villani P, Pregnolato M, Banfo S, Rettani M, Burroni D, Seminari E, Maserati R, Regazzi MB.

Ther Drug Monit. 1999 Jun;21(3):346-50.

PMID:
10365651
10.

Simultaneous determination of 16 anti-HIV drugs in human plasma by high-performance liquid chromatography.

Notari S, Bocedi A, Ippolito G, Narciso P, Pucillo LP, Tossini G, Donnorso RP, Gasparrini F, Ascenzi P.

J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Feb 2;831(1-2):258-66. Epub 2006 Jan 6.

PMID:
16406832
11.

Simple and rapid method for the simultaneous determination of the non-nucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma using liquid chromatography.

Kappelhoff BS, Rosing H, Huitema AD, Beijnen JH.

J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jul 25;792(2):353-62.

PMID:
12860043
12.
13.

Determination of efavirenz in human plasma by high-performance liquid chromatography with ultraviolet detection.

Saras-Nacenta M, López-Púa Y, Lípez-Cortés LF, Mallolas J, Gatell JM, Carné X.

J Chromatogr B Biomed Sci Appl. 2001 Nov 5;763(1-2):53-9.

PMID:
11710583
14.

Simultaneous determination of efavirenz, rifampicin and its metabolite desacetyl rifampicin levels in human plasma.

Fox D, O'Connor R, Mallon P, McMahon G.

J Pharm Biomed Anal. 2011 Dec 5;56(4):785-91. doi: 10.1016/j.jpba.2011.07.041. Epub 2011 Jul 30.

PMID:
21840662
16.

Intra-individual variability in efavirenz plasma concentrations supports therapeutic drug monitoring based on quarterly sampling in the first year of therapy.

Pereira SA, Branco T, Caixas U, Côrte-Real RM, Germano I, Lampreia F, Monteiro EC.

Ther Drug Monit. 2008 Feb;30(1):60-6. doi: 10.1097/FTD.0b013e318160ce76.

PMID:
18223464
17.

Plasma concentrations, efficacy and safety of efavirenz in HIV-infected adults treated for tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA trial).

Borand L, Madec Y, Laureillard D, Chou M, Marcy O, Pheng P, Prak N, Kim C, Lak KK, Hak C, Dim B, Nerrienet E, Fontanet A, Sok T, Goldfeld AE, Blanc FX, Taburet AM.

PLoS One. 2014 Mar 7;9(3):e90350. doi: 10.1371/journal.pone.0090350. eCollection 2014.

18.
19.

Validation of an electrospray ionization LC-MS/MS method for quantitative analysis of raltegravir, etravirine, and 9 other antiretroviral agents in human plasma samples.

Quaranta S, Woloch C, Paccou A, Giocanti M, Solas C, Lacarelle B.

Ther Drug Monit. 2009 Dec;31(6):695-702. doi: 10.1097/FTD.0b013e3181c05adf.

PMID:
19865000
20.

Therapeutic drug monitoring of the HIV/AIDS drugs abacavir, zidovudine, efavirenz, nevirapine, indinavir, lopinavir, and nelfinavir.

Donnerer J, Kronawetter M, Kapper A, Haas I, Kessler HH.

Pharmacology. 2003 Dec;69(4):197-204.

PMID:
14624060
Items per page

Supplemental Content

Write to the Help Desk